Breast cancer: Study identifies a molecular mechanism of drug resistance in ER+ tumor [Archive]

View Full Version : Breast cancer: Study identifies a molecular mechanism of drug resistance in ER+ tumor

News

03-21-2017, 08:10 AM

Study suggests that a mechanism of drug resistance in ER+ breast cancers could be changes to the estrogen receptor caused by two immune system molecules.

More... (http://www.medicalnewstoday.com/articles/316492.php)